Meritage Corporation (MTH)
Official siteCONSUMER CYCLICAL • RESIDENTIAL CONSTRUCTION • NYSE
Market Cap: $4.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Meritage Corporation (MTH) Stock Forecast
Analysts expect Meritage (MTH) to earn $4.35 per share in the fiscal year ending Dec 31, 2026, on revenue of $4.93B. Of 10 analysts, 3 rate the stock Buy or Strong Buy, 6 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.70, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 30% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 10.0% |
| Buy | 2 | 20.0% |
| Hold | 6 | 60.0% |
| Sell | 1 | 10.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 5.1% and revenue estimates rise 2.6%.
- Fiscal year ending Dec 31, 2026
- $4.35
- EPS consensus, revenue $4.93B
- Fiscal year ending Dec 31, 2027
- $4.57
- EPS consensus, revenue $5.06B
- Next report
- Jan 26, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.35 | $4.10 to $4.49 | 6 | $4.93B | $4.87B to $4.99B | 9 |
| Dec 31, 2027 | $4.57 | $3.45 to $5.85 | 7 | $5.06B | $4.77B to $5.39B | 9 |
Quarterly Estimates
The EPS consensus falls from $0.97 for the quarter ending Dec 31, 2026 to $0.73 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.97 | $0.69 to $1.34 | 12 | $1.23B | $1.14B to $1.36B | 12 |
| Mar 31, 2027 | $0.73 | $0.52 to $0.88 | 4 | $1.04B | $955.80M to $1.13B | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 8 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 0 | 4 |
| Quarter ending Mar 31, 2027 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 13.0% from $5.00.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.35 | $4.80 | $4.95 | $5.00 | $5.00 | -13.1% |
| Fiscal year ending Dec 31, 2027 | $4.57 | $5.50 | $5.87 | $6.10 | $6.10 | -25.1% |
| Quarter ending Mar 31, 2027 | $0.73 | $0.89 | $0.91 | $0.93 | $0.93 | -21.9% |
Frequently Asked Questions About MTH
What is the MTH stock forecast?
Consensus analyst estimates put Meritage's EPS at $4.35 for the fiscal year ending Dec 31, 2026, on revenue of $4.93B. The consensus rating from 10 analysts is Hold.
How do analysts rate MTH stock?
Of 10 analysts covering Meritage, 1 rates it Strong Buy, 2 Buy, 6 Hold, 1 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from MTH next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.35, with estimates from $4.10 to $4.49 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.57, with estimates from $3.45 to $5.85 from 7 analysts.
What revenue do analysts expect from Meritage next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $4.93B, with estimates from $4.87B to $4.99B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $5.06B, with estimates from $4.77B to $5.39B.
How many analysts cover MTH?
10 analysts rate Meritage stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
MTH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors